| This article has been cited by | | 1 | Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma | | | Richard A. Carr,Domenico Mesiano,Cynthia Heffron,Teodora Radonic,James Wiggins,Simon Tso,Rishi Agrawal,Elaine Cheung,David N. Slater,Linda Nichols,Paul Craig | | Pathology.2023;55(6)772 | | [DOI] | | | 2 | To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinoma | | | Mackenzie Poole,Robert A. Schwartz,W. Clark Lambert,Albert Alhatem | | Archives of Dermatological Research.2022;315(4)903 | | [DOI] | | | 3 | From editor's desk | | | Ranjan Agrawal | | Indian Journal of Pathology and Microbiology.2019;62(4)521 | | [DOI] | |
|
|
|
